Abstract
Esophageal squamous cell carcinoma (ESCC) is the leading malignancy in Huaian, China. Recently, emerging studies have suggested that an aberrant microRNA (miRNA) expression signature exists in ESCC. However, there is discordant information available on specific miRNA expression in patients from different regions. In this study, we identified 12 miRNAs that are differentially expressed in patients with ESCC from Huaian, China. Among these miRNAs that displayed unique miRNA expression signatures, miR-1, miR-29c, miR-100, miR-133a, miR-133b, miR-143, miR-145, and miR-195 were downregulated, and miR-7, miR-21, miR-223, and miR-1246 were upregulated in cancerous tissue compared with the adjacent normal tissue. Bioinformatics analyses identified the major biological processes and signaling pathways that are targeted by these differentially expressed miRNAs. Accordingly, miR-29c, miR-100, miR-133a, and miR-133b were found to be involved in invasion and metastasis of ESCC, and miR-7 and miR-21 were found to be related to the differentiation of ESCC. Thus, our data present new evidence for the important roles of miRNAs in ESCC.
Similar content being viewed by others
References
Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116(2), 281–297.
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120(1), 15–20.
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834–838.
Calin, G. A., & Croce, C. M. (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer, 6(11), 857–866.
Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., & Bushell, M. (2012). microRNAs in cancer management. The Lancet Oncology, 13(6), e249–e258.
Jia, X. Q., Cheng, H. Q., Qian, X., Bian, C. X., Shi, Z. M., Zhang, J. P., et al. (2012). Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Cell Biochemistry and Biophysics, 62(1), 237–244.
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America, 101(9), 2999–3004.
Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917.
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90.
He, B., Yin, B., Wang, B., Xia, Z., Chen, C., & Tang, J. (2012). MicroRNAs in esophageal cancer (review). Molecular Medicine Reports, 6(3), 459–465.
Smith, C. M., Watson, D. I., Michael, M. Z., & Hussey, D. J. (2010). MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma. World Journal of Gastroenterology, 16(5), 531–537.
Mathe, E. A., Nguyen, G. H., Bowman, E. D., Zhao, Y., Budhu, A., Schetter, A. J., et al. (2009). MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival. Clinical Cancer Research, 15(19), 6192–6200.
Feber, A., Xi, L., Luketich, J. D., Pennathur, A., Landreneau, R. J., Wu, M., et al. (2008). MicroRNA expression profiles of esophageal cancer. Journal of Thoracic and Cardiovascular Surgery, 135(2), 255–260.
Ogawa, R., Ishiguro, H., Kuwabara, Y., Kimura, M., Mitsui, A., Katada, T., et al. (2009). Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Medical Molecular Morphology, 42(2), 102–109.
Guo, Y., Chen, Z., Zhang, L., Zhou, F., Shi, S., Feng, X., et al. (2008). Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Research, 68(1), 26–33.
Matsushima, K., Isomoto, H., Yamaguchi, N., Inoue, N., Machida, H., Nakayama, T., et al. (2011). MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. Journal of Translational Medicine, 9, 30.
Ke, L. (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. International Journal of Cancer, 102(3), 271–274.
Li, Q. W., Yuan, G. J., Du, Y. X., Pan, E. C., & He, Y. (2012). Investigation of epidemic and treatment status of esophageal cancer in Huai’an area. Chinese Clinical Oncology, 17(2), 142–145.
Wang, L. D., Zhou, F. Y., Li, X. M., Sun, L. D., Song, X., Jin, Y., et al. (2010). Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nature Genetics, 42(9), 759–763.
Sun, G., Wang, S., Hu, X., Su, J., Huang, T., Yu, J., et al. (2007). Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Additives and Contaminants, 24(2), 181–185.
Zhu, Q., Hong, A., Sheng, N., Zhang, X., Matejko, A., Jun, K. Y., et al. (2007). Microparaflo biochip for nucleic acid and protein analysis. Methods in Molecular Biology, 382, 287–312.
Gao, X., Gulari, E., & Zhou, X. (2004). In situ synthesis of oligonucleotide microarrays. Biopolymers, 73(5), 579–596.
Bolstad, B. M., Irizarry, R. A., Astrand, M., & Speed, T. P. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19(2), 185–193.
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., et al. (2000). Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nature Genetics, 25(1), 25–29.
Dennis, G. J., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology, 4(5), P3.
Nagaraja, A. K., Creighton, C. J., Yu, Z., Zhu, H., Gunaratne, P. H., Reid, J. G., et al. (2010). A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocrinology, 24(2), 447–463.
Ambros, V. (2004). The functions of animal microRNAs. Nature, 431(7006), 350–355.
Wu, B. L., Xu, L. Y., Du, Z. P., Liao, L. D., Zhang, H. F., Huang, Q., et al. (2011). MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145. World Journal of Gastroenterology, 17(1), 79–88.
Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., et al. (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clinical Cancer Research, 15(6), 1915–1922.
Chabalier, J., Mosser, J., & Burgun, A. (2007). A transversal approach to predict gene product networks from ontology-based similarity. BMC Bioinformatics, 8, 235.
Lioni, M., Noma, K., Snyder, A., Klein-Szanto, A., Diehl, J. A., Rustgi, A. K., et al. (2008). Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. Molecular Cancer Therapeutics, 7(9), 2866–2875.
Naganuma, S., Whelan, K. A., Natsuizaka, M., Kagawa, S., Kinugasa, H., Chang, S., et al. (2012). Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. American journal of cancer research, 2(4), 459–475.
Li, H., Gao, Q., Guo, L., & Lu, S. H. (2011). The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biology and Therapy, 11(11), 950–958.
Zhao, X., & Guan, J. L. (2011). Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Advanced Drug Delivery Reviews, 63(8), 610–615.
Schwock, J., Dhani, N., & Hedley, D. W. (2010). Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opinion on Therapeutic Targets, 14(1), 77–94.
Pass, H. I., Goparaju, C., Ivanov, S., Donington, J., Carbone, M., Hoshen, M., et al. (2010). hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Research, 70(5), 1916–1924.
Wu, Z. S., Wang, C. Q., Xiang, R., Liu, X., Ye, S., Yang, X. Q., et al. (2012). Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer, 12, 51.
Akcakaya, P., Ekelund, S., Kolosenko, I., Caramuta, S., Ozata, D. M., Xie, H., et al. (2011). miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. International Journal of Oncology, 39(2), 311–318.
Leite, K. R., Sousa-Canavez, J. M., Reis, S. T., Tomiyama, A. H., Camara-Lopes, L. H., Sanudo, A., et al. (2011). Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urologic Oncology, 29(3), 265–269.
Prochnik, S. E., Rokhsar, D. S., & Aboobaker, A. A. (2007). Evidence for a microRNA expansion in the bilaterian ancestor. Development Genes and Evolution, 217(1), 73–77.
Christodoulou, F., Raible, F., Tomer, R., Simakov, O., Trachana, K., Klaus, S., et al. (2010). Ancient animal microRNAs and the evolution of tissue identity. Nature, 463(7284), 1084–1088.
Li, B. H., Zhou, J. S., Ye, F., Cheng, X. D., Zhou, C. Y., Lu, W. G., et al. (2011). Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. European Journal of Cancer, 47(14), 2166–2174.
Shi, W., Alajez, N. M., Bastianutto, C., Hui, A. B., Mocanu, J. D., Ito, E., et al. (2010). Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. International Journal of Cancer, 126(9), 2036–2048.
Henson, B. J., Bhattacharjee, S., O’Dee, D. M., Feingold, E., & Gollin, S. M. (2009). Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes, Chromosomes and Cancer, 48(7), 569–582.
Chou, Y. T., Lin, H. H., Lien, Y. C., Wang, Y. H., Hong, C. F., Kao, Y. R., et al. (2010). EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Research, 70(21), 8822–8831.
Jung, H. M., Phillips, B. L., Patel, R. S., Cohen, D. M., Jakymiw, A., Kong, W. W., et al. (2012). Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer. Journal of Biological Chemistry, 287(35), 29261–29272.
Liu, M., Tang, Q., Qiu, M., Lang, N., Li, M., Zheng, Y., et al. (2011). miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Letters, 585(19), 2998–3005.
Selcuklu, S. D., Donoghue, M. T., & Spillane, C. (2009). miR-21 as a key regulator of oncogenic processes. Biochemical Society Transactions, 37(Pt 4), 918–925.
Zhu, Q., Wang, Z., Hu, Y., Li, J., Li, X., Zhou, L., et al. (2012). miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncology Reports, 27(5), 1660–1668.
Zhang, Z., Li, Z., Gao, C., Chen, P., Chen, J., Liu, W., et al. (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation, 88(12), 1358–1366.
Acknowledgments
The Natural Science Foundation of Jiangsu Province China (BK2012666).
Conflict of interest
The authors declare that no conflict of interest exists in relation to the content of this article.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Hai Long Fu, De Ping Wu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
12013_2013_9554_MOESM5_ESM.tif
miR-1, miR-29c, miR-100, miR-133a, miR-133b, miR-143, miR-145, miR-195, miR-7, miR-21, miR-223, and miR-1246 expression levels in 34 patients with ESCC (TIFF 39 kb)
Rights and permissions
About this article
Cite this article
Fu, H.L., Wu, D.P., Wang, X.F. et al. Altered miRNA Expression is Associated with Differentiation, Invasion, and Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) in Patients from Huaian, China. Cell Biochem Biophys 67, 657–668 (2013). https://doi.org/10.1007/s12013-013-9554-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-013-9554-3